Octane Exo Inc.: federal grants and contributions: 2 agreements; $1.1M value; 1 departments; 1 programs.
Assay record ASY-CA-11BOHTN082 · Cite as: Assay Systems, “Octane Exo Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/octane-exo-inc/
Octane EXO is focused on the development, manufacturing and regulatory approval of innovative spinal implants formed from a proprietary biocomposite that provides superior bone tissue integration for spinal reconstruction. This project is directed to the completion of product and process R&D along with the the qualification of the manufacturing methods, as key objectives leading to submission for regulatory approval by international health agencies. Following regulatory approval, Octane EXO will commercialize via leading multinational partners.
Octane EXO is exploring the technical, financial and logistical feasibility of a new project focused on the development, manufacturing and regulatory approval of an innovative and proprietary biocomposite for spinal reconstruction.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.